All news

Cigna lobbying spend hits $60,000 as CI trades 18% below target

Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash

THE CIGNA GROUP AND SUBSIDIARIES (CI) recently disclosed $60,000 in lobbying expenditures for Q3 2026, focusing on federal tax and healthcare issues. Insider trading data shows primarily sales by executives, while institutional investors had mixed activity, with some adding and others reducing their positions. Analysts have set a median price target of $338.0 for CI, based on recent assessments.

Read original source

CI company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.